Omega Protein Corp

Omega Protein — Proxy Contest (June 2016)

36 slides from Omega Protein's proxy contest presentation, Jun 7, 2016

  1. Slide 1: Omega Protein: Healthy Products for a Healthy World

    OMEGA PROTEIN’ Healthy Products for a Healthy World

  2. Slide 2: Table of Contents

    Q Oo; Table of Contents fo) = R¢ 1) Omega is implementing a clear strategy to deliver maximized, long-term returns for stockholders 2) Strategy producing strong financial results 3) Qualified Board and management acting in the best interests of ALL stockholders 4) Hand-picked Wynnefield nominee, Mic

  3. Slide 3: Building a Stronger Nutrition Company

    Building a Stronger Nutrition Company Broad Spectrum of End Markets Served —_ Blue-Chip Nutrition Customers 17% | 21% cag EF ERR || S IAMS® 7) AQUACULTURE] COMPANION Livestock _f SUPPLEMENT = ADM BioM A j 2) ‘ mana at VI GNC LiveWell URINA % of Revenue by Product Category 2015 | Global Distribution

  4. Slide 4: Expanding Customer Segments

    Expanding Customer Segments Board carefully considered decision to expand into Human Nutrition to further strengthen Omega Protein o Began exploring opportunities in early 2000's o Developed strategy to diversify revenues without sacrificing continued investment in Animal Nutrition business * Invest

  5. Slide 5: Macro Trends Support Long-Term Growth

    Macro Trends Support Long-Term Growth , more health conscious ulation seeks more n Growing Global Population* 2015e | 7.3bn Growing Global Middle Class? Increased purchasing power towards more nourishing, appetizing and safe foods 2009 2020 2030 Growing Aging Population? 14.1% 21:E% 2013 2040 Older

  6. Slide 6: Clear Strategy to Increase Stockholder Value

    Clear Strategy to Increase Stockholder Value 1. Drive sales growth 2. Focus on efficiency & « Expand sales to existing cost structure customers and acquire new customers ¢ De-bottleneck assets and improve capacity utilization « Develop new products and line + Lower operating costs extensions OMEGA 6

  7. Slide 7: Vertically Integrated Model

    Vertically Integrated Model Integration allows creation of differentiated products, control over sourcing & reduced costs DEVELOP SOURCE PROCESS BLEND & MARKET & <2 S Y PACKAGE SELL € SUPPLY CHAIN =—7 vertically integrate or outsource as appropriate

  8. Slide 8: What Do Omega's Analysts Say?

    2 What Do Omega’s Analysts Say? "The company is in no way capital-constrained in the Animal Nutrition business. Thus, we conclude that it would make ZERO sense to exit Human Nutrition today... We are happy with [the result of the strategic review] and if the Human Nutrition business can improve its

  9. Slide 9: Table of Contents

    Table of Contents Q Oo; fo) = R¢ EGA 1) Omega is implementing a clear strategy to deliver maximized, long-term returns for stockholders 2) Strategy producing strong financial results 3) Qualified Board and management acting in the best interests of ALL stockholders 4) Hand-picked Wynnefield nominee,

  10. Slide 10: Strong Fundamentals

    2 Strong Fundamentals REVENUE 2011-2015 Million US. $ $359 309 2011 2012 2013 2014 2015 mAnimal — @ Human GROSS PROFIT & MARGIN 2011-2015 Million US. $ 34% 2011 2012 2013 2014 2015 mmm Gross Profit ——Gross Margin OMEGA PROTEIN’ Top line growth across businesses Strong cash flow generation with 5-yea

  11. Slide 11: Favorably Positioned vs. Peers

    $60 $50 $30 $20 $10 $0 OMEGA I PMESK (1) See Appendix for Favorably Positioned vs. Peers ADJUSTED EBIT? MARGIN 2011-2015 Million US. 25% 2011 2012 2013 2014 2015 WmMEEBIT ——=EBIT Margin fon of Adjusted EBIT to net ins OPERATING MARGINS compare FAVORABLY to peers PEER GROUP MEDIAN 2015 EBIT % 13.2% 1

  12. Slide 12: Strong EBITDA Profile & Balance Sheet

    $90 $80 $70 $60 $50 $40 $30 $20 $10 $0 OMEGA I OMESK a =F EBIT Strong EBITDA Profile & Balance Sheet EBITDA! 2011-2015 31% 2011 «2012-2 2013S «2014-2015 mmm EBITDA] ——EBITDA Margin 35% 30% 25% 20% 15% 10% 5% 0% DEBT* BALANCE 2011-2015 Million US.$ 2011 2012 2013 2014 2015 * Debt includes capital lea

  13. Slide 13: Delivering Stockholder Value

    Delivering Stockholder Value The Board's strategic steps have created value for stockholders since Bret Scholtes’ appointment as CEO in 2012 “Yau 2012 Brat D, Stes appointed $20 President nd CED Mari, 2018 Vjneeied Anden CSohannesen appintes EVP amrouncedtsintenton and CFO. Aug 11.2015 ‘nominate a s

  14. Slide 14: TSR Performance Since CEO Change

    TSR Performance Since CEO Change Omega has outperformed a diversified peer set and the broader market since Bret Scholtes’ appointment as CEO in 2012 300% Omega Protein Corporation's TSR performance vs. peer group? and relevant indexes (Jan 2012 - May 20162) Jan-12 Jan-13 Jan-14 Jan-15 Jan-16 — Omeg

  15. Slide 15: 1-Year TSR Performance

    1-Year TSR Performance Omega has outperformed a diversified peer set and the broader market over the last 12 months 100% Omega Protein Corporation's TSR performance vs. peer group? and relevant indexes (May 2015 - May 20162) 80% 60% 40% 20% 0% 40% May-18 Jun15 — Jul-15—Aug45— Sep-15 Oct-15 = Nov Dec

  16. Slide 16: 3-Year TSR Performance

    3-Year TSR Performance Omega has outperformed a diversified peer set and the broader market over the last three years 2 140% Omega Protein Corporation's TSR performance vs. peer group? and relevant indexes (May 2013 - May 20162) 120% May-13 May-14 May-15 Omega Protein Corporation: 7% —Russell 2000:

  17. Slide 17: 5-Year TSR Performance

    5-Year TSR Performance Omega has outperformed the Russell 2000 over the last five years 140% Omega Protein Corporation's TSR performance vs. peer group! and relevant indexes (May 2011 - May 2016?) r 120% May-lt May-12 May-13 May-14 May-15 Omega Protein Corporation: 50% — Russel 2000: 36% — sap 500:6

  18. Slide 18: 10-Year TSR Performance

    10-Year TSR Performance Omega has outperformed a diversified peer set and the broader market over the last ten years 350% Omega Protein Corporation's TSR performance vs. peer group? and relevant indexes (May 2006 - May 20162) 300% 100% May06 May07 May08 May-09 May-10 May-lt May-12 May-13 May-14 May-

  19. Slide 19: Calendar Year and Multi-Year Performance

    Calendar 1, 3 and 5 Year Performance Omega outperformed a diversified peer set and the broader market in 2015, as well as over the 2013-2015 and 2011-2015 periods 2015" 2013-2015”) 2011-2015") Omega Protein 110.0% 262.7% 174.1% Russell 2000 5.7% 33.7% 44.9% S&P 500 -0.7% 43.3% 62.5% Peer Group") -11

  20. Slide 20: Table of Contents

    Q Oo; Table of Contents fo) = R¢ EGA ) 2) 4) TEIN’ Omega is implementing a clear strategy to deliver maximized, long-term returns for stockholders Strategy producing strong financial results Qualified Board and management acting in the best interests stockholders Hand-picked Wynnefield nominee, Mich

  21. Slide 21: Board's Recent Stockholder-Friendly Actions

    Board's Recent Stockholder-Friendly Actions 2014: + Terminated stockholder rights plan once its purpose to protect against opportunistic . aunges control 2015: 2or following 2010 BP oil spill . Board + Separated the was served commenced combined + Implemented equity review of Chairman/CEO ownership

  22. Slide 22: Review of Strategic Alternatives

    2 Review of Strategic Alternatives OMEGA PROTEIN’ Board authorized a strategic review in September 2015 o Hired J.P Morgan to assist with process o Full Board actively involved in managing process — 17 Board meetings between September 1, 2015 and May 31, 2016 o Strategic review consistent with Board

  23. Slide 23: Fresh Perspective Through Changes in Board Composition

    Fresh Perspective Through Changes in Board Composition 2010 2016 Joseph Von Rosenberg (Chairman) Gary R. Goodwin Dr. Gary L. Allee Dr. Bill Lands Paul M. Kearns Harry Nicodemus Gary R. Goodwin (Chairman) Dr. Gary L. Allee David A. Owen (joined in 2010) David W. Wehlmann (joined in 2012) Bret D. Scho

  24. Slide 24: Corporate Governance Highlights

    Corporate Governance Highlights Paul Kearns after a majority of withhold votes in 2013 candidate - without requiring settlement agreement Refreshed 7 directors of 7 of 8 directors are Independent Chairman current 8-member Board independent of the Board since 2010 (if Clarke is elected): Proposed maj

  25. Slide 25: Our Qualified Candidates

    Our Qualified Candidates Gary J. Ermers (irectorsince 2014) + Former Chief Financial Officer of St. Joseph Health System and KentuckyOne Health + Extensive healthcare knowledge critical for expansion into human nutrition with increased healthcare industry focus on wellness and preventive care + Expe

  26. Slide 26: Table of Contents

    Table of Contents 1) Omega is implementing a clear strategy to deliver maximized, long-term returns for stockholders 2) Strategy producing strong financial results 3) Qualified Board and management acting in the best interests of ALL stockholders Hand-picked Wynnefield nominee, Michael Christodolou,

  27. Slide 27: Our History with Wynnefield

    Our History with Wynnefield Refuses reasonable settlement Wynnefield originally demanded only one board seat After nomination notice, Wynnefield offered to settle on two Board seats Wynnefield responded to Omega compromise offer of one board seat by demanding three directors Even after Board nominat

  28. Slide 28: Christodolou's Lack of Relevant, Additive Skills

    Christodolou's Lack of Relevant, Additive Skills 2 Mr. Christodolou Mr. Ermers Full Board Nutrition and Wellness x ¥ « Wellness industry Bryan, Ermers, Scholtes Scholtes Operational Risk 4 v we Monceement Duties Ermers, Scholtes Direct Finance & Audit x Vv we Audit Experience Ermers, Scholtes, Wehim

  29. Slide 29: Mr. Christodolou's Questionable Independence

    Mr. Christodolou's Questionable Independence Why did Wynnefield stubbornly insist on the appointment of Mr. Christodolou for the last 9 months, despite his apparent lack of additive skills? * In its only written settlement proposal dated April 8, 2016, Wynnefield insisted that its Board nominees wou

  30. Slide 30: Wynnefield Fails to Present Long-Term Strategy to Create Stockholder Value

    Wynnefield Fails to Present Long-Term Strategy to Create Stockholder Value Core planks of the Wynnefield “plan” all plainly refuted: x “Disappointing Strategic Review” + FACT: Exhaustive review with leading financial advisor evaluated indications of interest and implemented a stock buyback program x

  31. Slide 31: Wynnefield Always Pushed for a Sale, Offering No Other Strategy

    Wynnefield Always Pushed for a Sale, Offering No Other Strategy + Wynnefield Schedule 13D filed August 11, 2015 + "Your road forward must entail the immediate hiring of a reputable investment banking firm to explore all strategic alternatives to maximize and release shareholder value, including the

  32. Slide 32: Conclusion

    2 Conclusion THE CHOICE IS SIMPLE Wynnefield has launched a proxy contest to effect an immediate sale of Omega + No strategy to grow stockholder value other than a prompt sale of all or part of the business Board already evaluated sale, among other opportunities for value creation + Outside financia

  33. Slide 33: Appendix

    OMEGA ROMEO. APPENDIX

  34. Slide 34: Regulation G Reconciliation

    Regulation G Reconciliation The following table provides a reconciliation of Adjusted EBIT and Adjusted EBITDA*, non-GAAP (Generally Accepted ‘Accounting Principles) financial measures, to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, fo

  35. Slide 35: Regulation G Reconciliation

    Regulation G Reconciliation *Adjusted EBIT represents net income before interest expense, income tax, investigation charge, net loss on disposal of assets, the Gulf Coast Claims Facility (Deepwater Horizon claim) and 2008 and 2005 hurricane litigation settlements, impairment of intangible assets and

  36. Slide 36: Forward Looking Statements

    Forward Looking Statements The statements contained in this presentation that are not historical facts are forward-looking statements that involve a number of risks and uncertainties, Forward-looking information may be based on projections, predictions and estimates. In this presentation and in repo

Omega Protein — Proxy Contest (June 2016) on 6ix